Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SIGHT: Medical Therapy vs. ONSF vs. VPS for IIH with Visual Loss
NCT03501966Phase 3Terminated
- Sponsor
- Jaeb Center for Health Research
- Start
- Feb 2019
- Primary completion
- Aug 2019
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 3 trial of acetazolamide in idiopathic intracranial hypertension (IIH), sponsored by Jaeb Center for Health Research. Started Feb 2019; status: terminated.
02
Drugs
acetazolamide
03
Conditions
idiopathic intracranial hypertension (IIH)
Beyond the preview
Go deeper on NCT03501966.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03501966.